secwatch / observer
8-K filed May 23, 2023, 7:59 PM ET CIK 0001845459
other material confidence high sentiment negative materiality 0.80

Graf Acquisition Corp. IV extends deadline to Sept 29, 2023; $113.3M redeemed

NKGen Biotech, Inc.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

NKGen Biotech, Inc.: Amended certificate of incorporation to extend the deadline for initial business combination from May 25, 2023 to September 29, 2023, and allow board to elect an earlier wind-up date (effective 2023-05-22).

Change
charter amendment
Effective
2023-05-22
Exact text from the filing
the Company filed the Charter Amendment with the Secretary of State of the State of Delaware. A copy of the Charter Amendment is attached hereto as Exhibit 3.1.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

NKGen Biotech, Inc. shareholders approved Extension Amendment Proposal to amend the charter to extend the date to consummate an initial business combination from May 25, 2023 to September 29, 2023 and permit the board to elect an earlier wind-up. at the 2023-05-22 meeting.

Proposal
charter amendment
Outcome
passed
Meeting
2023-05-22
Exact text from the filing
Approval of Extension Amendment Proposal Votes For Votes Against Abstentions 17,513,683 1,057 0
View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR
accession 0001104659-23-063294
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.